Investigation Centre Region VI, Denpasar, Bali. On arrival, they were sprayed with 128 insecticide, kept in an insect-proof house and given water and elephant grass (Penecetum 129 purpureum) ad libitum. Prior to use, all cattle were pre-treated with a broad spectrum 130 antibiotic (oxytetracycline) at a dose rate of 5 mg/kg bodyweight for 3 consecutive days, a 131 broad spectrum anti-helmintic, and they were vaccinated against haemorrhagic septicaemia. 132
Before inoculation with JDV, the absence of antibody to JDV was confirmed by ELISA test 133 using a JDV recombinant CA antigen as described previously (Burkala et al., 1998) . 134
135
Five Bali cattle were infected intravenously with an estimated 100 infectious doses of JDV 136 contained in a 10% homogenate in Dulbecco's modified Eagle's medium of spleen which had 137 been stored at −70 °C and previously prepared from an animal experimentally infected with 138 JDV Tab87 (Soeharsono et al., 1995) . The febrile phase in the inoculated animals occurred from 139 5-11 days after infection. Blood samples were analysed prior to infection (day 0), at day 2 140 and daily from days 4 to 7 (febrile phase) and day 9 post-infection, and then finally at day 19 141 when the animals were euthanased for autopsy. Sterile EDTA-containing vacutainer tubes 
Antibodies and cellular markers 157
Lymphocyte subsets were labeled with 2.5 g/ml mouse anti-bovine CD4 mAb (Serotec, 158 UK), 5 g/ml mouse anti-bovine CD8 mAb (Serotec, UK) or 20 g/ml mouse anti-bovine 159 CD21 mAb (Santa Cruz, USA) as a B-cell marker. An Alexa Fluor 488 (AF488) conjugated 160 goat anti-mouse cross-absorbed secondary antibody (Invitrogen, Australia) was used to detect 161 all reactive mAb antibodies (Table 1) . 162
163

Cell surface labeling of lymphocytes 164
Due to Australian quarantine and logistical requirements, peripheral blood lymphocytes were 165 antibody-labeled and fixed on-site in Bali prior to transport to Australia for analysis by flow 166 cytometry at the University of Western Australia, using a previously validated protocol A c c e p t e d M a n u s c r i p t 28 
